Recombinant cholera toxin B subunit (rCTB) as a mucosal adjuvant enhances induction of diphtheria and tetanus antitoxin antibodies in mice by intranasal administration with diphtheria–pertussis–tetanus (DPT) combination vaccine

This publication has 45 references indexed in Scilit:

• Tracking the tissue distribution of marker dye following intranasal delivery in mice and chinchillas: a multifactorial analysis of parameters affecting nasal retention
  Vaccine, 2002
• Musosal immunoadjuvant activity of recombinant Escherichia coli heatlabile enterotoxin and its B subunit: Induction of systemic IgG and secretory IgA responses in mice by intranasal immunization with influenza virus surface antigen
  Vaccine, 1998
• Systemic and mucosal immune responses of mice to aluminium-adsorbed or aluminium-non-adsorbed tetanus toxoid administered intranasally with recombinant cholera toxin B subunit
  Vaccine, 1998
• Affinity purification of recombinant cholera toxin B subunit oligomer expressed inBacillus brevisfor potential human use as a mucosal adjuvant
  FEMS Immunology & Medical Microbiology, 1998
• Relationship between a low toxicity of the mutant A subunit of enterotoxigenic Escherichia coli enterotoxin and its strong adjuvant action
  Immunology, 1997
• Adjuvant activity of Escherichia coli heat-labile enterotoxin and effect on the induction of oral tolerance in mice to unrelated protein antigens
  Vaccine, 1988
• Host Defense Mechanisms at Mucosal Surfaces
  Annual Review of Microbiology, 1981
• Antigenic Specificity of Antibodies in Vaginal Secretions during Infection with Neisseria gonorrhoeae
  The Journal of Infectious Diseases, 1980
• Inhibition of Bacterial Adherence by Secretory Immunoglobulin A: A Mechanism of Antigen Disposal
  Science, 1972
• Tetanus antitoxin titration by haemagglutination
  Epidemiology and Infection, 1957